Guru Ownership Trend
Guru Analysis for Tarsus Pharmaceuticals, Inc. (TARS)
Tarsus Pharmaceuticals, Inc. (TARS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $13.89 M.
Top institutional holders include Jefferies Group and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $18.31 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 87.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Tarsus Pharmaceuticals, Inc. (TARS)
Major holders include Jefferies Group ($8.33 M), Cliff Asness ($2.64 M), John Hussman ($1.32 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 200,654 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $18.31 M, with 3 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited TARS. The total reported sell value was $19.91 M.
Yes, 1 managers opened new positions in TARS, and 2 increased their existing holdings. The total reported buy value was $1.59 M.